iZafe Group launches Dosell version 3.0 and moves production

iZafe Group AB ("iZafe Group") is pleased to announce the launch of Dosell version 3.0, the latest edition of our revolutionary medication robot, designed to optimize medication management for users worldwide. In connection with this launch, iZafe Group has also initiated a strategic move of its production to Central Europe in order to be able to scale up the production rate to larger volumes and shorten the delivery distances to existing partners.

The first production run of 1,000 pieces of Dosell version 3.0 has been successfully completed and delivered for the Dutch market, marking the starting point for this new and improved version. With, among other things, a more powerful processor and increased memory capacity, Dosell version 3.0 now enables a unified software platform regardless of geographical location or design of the sachet bag. This represents a significant improvement from previous versions that required extensive customization for each individual country and sachet type. In addition, the new version of Dosell 3.0 introduces several advanced features, including voice and expanded connectivity options, further improving the user experience and accessibility.

"The launch of Dosell version 3.0 is an important milestone for us. The new components in this version not only enable a higher and better performance of existing functions, but also open up a wide range of new and innovative functions in the future. All this, without significantly affect the production cost, thanks to the progress made in the component market since Dosell's first version was developed." Says Anders Segerström, CEO of Zafe Group.

This strategic investment in innovation and product development, together with the relocation of production to Central Europe, positions iZafe Group at the forefront of medical technology solutions. With Dosell version 3.0, iZafe Group can now offer an even more reliable and efficient medicine management solution, making it easier for users worldwide to take the right medicine at the right time.

Datum 2024-02-23, kl 12:00
Källa MFN
Vill du synas här? Kontakta hej@allaaktier.se. Vår sajt har 100 000 sidvisningar och 15 000 unika besökare per månad. Vår discord har över 6000 medlemmar. Detta är aktiva sparare med ett stort aktieintresse. Behöver du nå ut till denna målgrupp så hör av dig!